• Tue, December 1, 2015
  • Wed, December 2, 2015
  • Thu, December 3, 2015
  • Fri, December 4, 2015
  • Mon, December 7, 2015
  • Tue, December 8, 2015
  • Wed, December 9, 2015

Paul Matteis Initiated (VRTX) at Strong Buy and Held Target at $125 on, Dec 1st, 2015

Paul Matteis of Stifel, Initiated "Vertex Pharmaceuticals Incorporated" (VRTX) at Strong Buy and Held Target at $125 on, Dec 1st, 2015.

Paul has made no other calls on VRTX in the last 4 months.



There are 4 other peers that have a rating on VRTX. Out of the 4 peers that are also analyzing VRTX, 1 agrees with Paul's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Biren Amin of "Jefferies" Initiated at Hold and Held Target at $130 on, Wednesday, September 9th, 2015


These are the ratings of the 3 analyists that currently disagree with Paul


  • Andrew Fein of "HC Wainwright & Co." Upgraded from Hold to Strong Buy and Increased Target to $155 on, Friday, October 30th, 2015
  • Matthew Harrison of "Morgan Stanley" Upgraded from Hold to Buy and Increased Target to $148 on, Friday, October 2nd, 2015
  • Jasper Hellweg of "Argus Research" Upgraded from Hold to Strong Buy on, Monday, September 28th, 2015